About Kaiser Permanente
Services
Type of Care
Substance use treatment; Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Outpatient; Outpatient day treatment or partial hospitalization; Intensive outpatient treatment; Outpatient methadone/buprenorphine or naltrexone treatment; Regular outpatient treatment
Opioid Medications used in Treatment
Buprenorphine used in Treatment; Naltrexone used in Treatment
Type of Alcohol Use Disorder Treatment
This facility administers/prescribes medication for alcohol use disorder
External Source of Medications Used for Alcohol Use Disorder Treatment
In-network prescribing entity
Type of Opioid Treatment
Buprenorphine maintenance; Prescribes buprenorphine; Prescribes naltrexone; Relapse prevention with naltrexone; Lofexidine or Clonidine detoxification
Pharmacotherapies
Acamprosate (Campral®); Disulfiram; Buprenorphine sub-dermal implant; Buprenorphine with naloxone; Buprenorphine without naloxone; Buprenorphine (extended-release, injectable); Naltrexone (oral); Naltrexone (extended-release, injectable); Clonidine; Medication for mental disorders; Non-nicotine smoking/tobacco cessation
Treatment Approaches
Brief intervention; Cognitive behavioral therapy; Motivational interviewing; Matrix Model; Relapse prevention; Substance use disorder counseling; Telemedicine/telehealth therapy; Trauma-related counseling
Facility Operation (e.g., Private, Public)
Private for-profit organization
License/Certification/Accreditation
State department of health; Hospital licensing authority; The Joint Commission; National Committee for Quality Assurance (NCQA)
Payment/Insurance/Funding Accepted
Medicare; Medicaid; Private health insurance; Cash or self-payment
Special Programs/Groups Offered
Clients with co-occurring mental and substance use disorders
Assessment/Pre-treatment
Comprehensive mental health assessment; Comprehensive substance use assessment; Complete medical history/physical exam; Screening for tobacco use; Screening for substance use; Screening for mental disorders
Testing
Breathalyzer or blood alcohol testing; Drug and alcohol oral fluid testing; Drug or alcohol urine screening
Transitional Services
Aftercare/continuing care; Discharge Planning; Naloxone and overdose education
Education and Counseling Services
Substance use disorder education; Individual counseling; Group counseling; Family counseling; Marital/couples counseling
Medical Services
Hepatitis A (HAV) vaccination; Hepatitis B (HBV) vaccination
Facility Smoking Policy
Smoking not permitted
Age Groups Accepted
Children/Adolescents; Adults
Sex Accepted
Female; Male
Language Services
Spanish; Sign language services for the deaf and hard of hearing
Facility Vaping Policy
Vaping not permitted
Ancillary Services
Case management service; Mental health services; Social skills development; Integrated primary care services; Suicide prevention services
Type of Care
Substance use treatment; Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Outpatient; Outpatient day treatment or partial hospitalization; Intensive outpatient treatment; Outpatient methadone/buprenorphine or naltrexone treatment; Regular outpatient treatment
Opioid Medications used in Treatment
Buprenorphine used in Treatment; Naltrexone used in Treatment
Type of Alcohol Use Disorder Treatment
This facility administers/prescribes medication for alcohol use disorder
External Source of Medications Used for Alcohol Use Disorder Treatment
In-network prescribing entity
Type of Opioid Treatment
Buprenorphine maintenance; Prescribes buprenorphine; Prescribes naltrexone; Relapse prevention with naltrexone; Lofexidine or Clonidine detoxification
Pharmacotherapies
Acamprosate (Campral®); Disulfiram; Buprenorphine sub-dermal implant; Buprenorphine with naloxone; Buprenorphine without naloxone; Buprenorphine (extended-release, injectable); Naltrexone (oral); Naltrexone (extended-release, injectable); Clonidine; Medication for mental disorders; Non-nicotine smoking/tobacco cessation
Treatment Approaches
Brief intervention; Cognitive behavioral therapy; Motivational interviewing; Matrix Model; Relapse prevention; Substance use disorder counseling; Telemedicine/telehealth therapy; Trauma-related counseling
Facility Operation (e.g., Private, Public)
Private for-profit organization
License/Certification/Accreditation
State department of health; Hospital licensing authority; The Joint Commission; National Committee for Quality Assurance (NCQA)
Payment/Insurance/Funding Accepted
Medicare; Medicaid; Private health insurance; Cash or self-payment
Special Programs/Groups Offered
Clients with co-occurring mental and substance use disorders
Assessment/Pre-treatment
Comprehensive mental health assessment; Comprehensive substance use assessment; Complete medical history/physical exam; Screening for tobacco use; Screening for substance use; Screening for mental disorders
Testing
Breathalyzer or blood alcohol testing; Drug and alcohol oral fluid testing; Drug or alcohol urine screening
Transitional Services
Aftercare/continuing care; Discharge Planning; Naloxone and overdose education
Education and Counseling Services
Substance use disorder education; Individual counseling; Group counseling; Family counseling; Marital/couples counseling
Medical Services
Hepatitis A (HAV) vaccination; Hepatitis B (HBV) vaccination
Facility Smoking Policy
Smoking not permitted
Age Groups Accepted
Children/Adolescents; Adults
Sex Accepted
Female; Male
Language Services
Spanish; Sign language services for the deaf and hard of hearing
Facility Vaping Policy
Vaping not permitted
Ancillary Services
Case management service; Mental health services; Social skills development; Integrated primary care services; Suicide prevention services
